pharmaphorum10d
GSK's CEO Walmsley aiming for six new approvals in 2020
Walmsley said there is a lot of data expected in 2020. Walmsley said in the interview that the next year could see “at least six approvals of new medicines or new indications”. GSK is asking ...
Business Insider3d
GlaxoSmithKline Cap. PLCLS-Medium-Term Nts 2020(20/28) Bond
The GlaxoSmithKline Capital PLC-Bond was issued on the 5/12/2020 with a volume of 750 M. GBP. Indices Commodities Currencies Stocks ...
GlaxoSmithKline: Sell Rating Amidst Weak Vaccine Performance and Projected EPS Decline
GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from ...
GSK, Pfizer seeing drop in demand for RSV vaccines: report
Sales of GSK (NYSE:GSK) and Pfizer’s (NYSE:PFE) RSV vaccines have reportedly fallen since U.S. regulators narrowed the ...
Business Insider5y
Drugmakers from Pfizer to GSK to hike US prices on over 200 drugs, as prescription drug prices become a hot 2020 campaign topic
NEW YORK (Reuters) - Drugmakers including Pfizer Inc <PFE.N>, GlaxoSmithKline PLC <GSK.L ... is running for re-election in 2020. Many branded drugmakers have pledged to keep their US list price ...